| Genmab A/S | 2,564.00 |
| Date/Time | 08/08 / 00:00 |
| Chg. / Chg.(%) | - / |
| Bid | 2,566.00 |
| Ask | 2,568.00 |
| Open | 2,574.00 |
| Previous Close | - |
| High | 2,598.00 |
| Low | 2,549.00 |
| Volume [DKK] | 237,420,017.00 |
| Volume [Units] | 94,235 |
| Price fixings | 3487 |
| ISIN | DK0010272202 |
| Security | GMAB |
| Exchange | OMX Nordic |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Cboe Europe .. | 2,576.00 |  |
24,450 |
| Turquoise | 2,574.00 | |
5,397 |
| London Inter.. | 2,576.0 | |
3,220 |
| TradeGate | 344.900 | |
96 |
| Cboe Europe .. | 2,574.00 |  |
33 |
| München | 343.80 | |
0 |
| Düsseldorf | 346.00 | |
0 |
| Hannover | 345.20 | |
0 |
| Frankfurt | 345.4000 | |
0 |
| Berlin | 344.70 | |
0 |
| Quotrix | 346.2000 | |
|
| Lang & Schwa.. | 345.70 | |
|
| Stuttgart | 344.800 | |
|
| gettex | 345.600 | |
|
| OMX Nordic | 2,564.00 | 94,235 | |
| Nasdaq Other.. | 349.9100 | 718 | |
| Cboe Europe .. | 2,580.00 | 13 | |
| Vienna Globa.. | 342.70 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire
Real-time